Literature DB >> 12434728

Which weight for weight-based dosage regimens in obese patients?

Brian L Erstad1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 12434728     DOI： 10.1093/ajhp/59.21.2105

Source DB:  PubMed          Journal:  Am J Health Syst Pharm        ISSN： 1079-2082            Impact factor:   2.637


× No keyword cloud information.
  4 in total

Review 1.  Therapeutic drug monitoring to adjust dosing in morbid obesity - a new use for an old methodology.

Authors:  Jennifer H Martin; Mohamed Saleem; David Looke
Journal:  Br J Clin Pharmacol       Date:  2012-05       Impact factor: 4.335

2.  Obesity and Pediatric Drug Development.

Authors:  Janelle D Vaughns; Laurie S Conklin; Ying Long; Panli Zheng; Fahim Faruque; Dionna J Green; John N van den Anker; Gilbert J Burckart
Journal:  J Clin Pharmacol       Date:  2018-01-19       Impact factor: 3.126

3.  Influence of daily dosage and frequency of administration of rifampicin-levofloxacin therapy on tolerance and effectiveness in 154 patients treated for prosthetic joint infections.

Authors:  S Nguyen; O Robineau; M Titecat; N Blondiaux; M Valette; C Loiez; E Beltrand; H Migaud; E Senneville
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2015-05-19       Impact factor: 3.267

4.  Efficacy and Safety of Eravacycline in Obese Patients: A Post Hoc Analysis of Pooled Data From the IGNITE1 and IGNITE4 Clinical Trials.

Authors:  Tomefa E Asempa; Sergey Izmailyan; Kenneth Lawrence; David P Nicolau
Journal:  Open Forum Infect Dis       Date:  2020-11-13       Impact factor: 3.835
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.